Therapeutic drug monitoring of teicoplanin using an LC–MS/MS method: Analysis of 421 measurements in a naturalistic clinical setting

Jung, J., Lee, K., Oh, J., Choi, R., Woo, H. I., Park, H. D., ... & Lee, S. Y.

Journal of pharmaceutical and biomedical analysis 167 (2019): 161-165.

Teicoplanin is a glycopeptide antibiotic used for treatment of severe Gram-positive bacterial infection. The aim of this study was to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for therapeutic drug monitoring (TDM) of teicoplanin and to review our clinical experience.We established an LC-MS/MS method to analyze serum concentration of teicoplanin using simple protein precipitation with a 5 min run time for each sample. The linearity, lower limit of quantitation, detection accuracy, precision, carryover, matrix effect, and extraction recovery were evaluated. From September 2014 to June 2017, a total of 421 serum teicoplanin concentrations was measured in 223 patients. We collected demographic and clinical data, medication history, and laboratory findings through retrospective review of medical records.The LC-MS/MS method was linear for serum teicoplanin concentrations in the range of 12.0-89.0 μg/mL. The intra- and inter-assay precisions were below CV 7.5%. The accuracy was less than ±10% bias. The lower limit of quantification was 0.2 μg/mL. The extraction recovery ranged from 88.8% to 96.6%. Of 421 measurements, 87 (20.7%) were subtherapeutic (< 10 μg/mL), and four (0.9%) were above the toxic threshold (≥ 60 μg/mL). Serum teicoplanin concentration was measured once in 140 patients (63%), and multiple measurements were completed for the others (83 patients, 37%). Intra-patient variability in teicoplanin concentration was found (CV 33%, range 2-94%).Our simple and rapid LC-MS/MS method was successfully applied in TDM of teicoplanin in clinical practice. Such TDM of teicoplanin may be useful for individualized dose adjustment.

Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition

Products Used in this Publication

Catalog NumberCASProduct NamePrice
B0084-30449461036-62-2TeicoplaninInquiry

Related Products

Catalog NumberCASProduct NamePrice
91032-26-791032-26-7Teicoplanin A2-2Inquiry
91032-34-791032-34-7Teicoplanin A2-1Inquiry
91032-36-991032-36-9Teicoplanin A2-3Inquiry
91032-37-091032-37-0Teicoplanin A2-4Inquiry
91032-38-191032-38-1Teicoplanin A2-5Inquiry